JMT601

· Shanghai JMT-Bio Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for JMT601, covering 2024-12-10 to 2025-06-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Learn More About the Effects and Safety of JMT601 in Adults With Primary Membranous Nephropathy [Phase 2]

See pricing